PENGARUH PEMBERIAN ASETAMINOFEN PRETREATMENT TERHADAP DERAJAT KERUSAKAN HEPAR TIKUS WISTAR YANG DIBERI DOSIS TOKSIK ASETAMINOFEN - Diponegoro University | Institutional Repository (UNDIP-IR)
DAFTAR PUSTAKA
1. MediMedia. MIMS Indonesia 1994; 23 (3). Singapore:MediMedia. 1994.
2. MediMedia. MIMS Indonesia 2003; 32 (2). Singapore:MediMedia. 2003.
3. Moynihan R. FDA fails to reduce accessibility of paracetamol despite 450 deaths a
year. BMJ 2002 Sept 28; 325..
4. Siker BPOM. Data keracunan parasetamol di Indonesia tahun 2002-2005, BPOM,
2006.
5. Schiodt FV, Lee WM. Fulminant liver disease. Clin Liver Dis 2003;7:331-49
6. Bromer MQ, Black M. Acetaminophen hepatotoxicity. Clin Liver Dis 2003;7:351-67
7. Martini. Fundamental of Anatomy and Physiology, 5th ed. London: Prentice Hall
Inc. 1999-2000.
8. Huether SE, Kathryn MC. Understanding Patophysiology, 2 nd edition. St Louis
USA: Mosby Inc. 2000: 931-33.
9. Tambunan GW. Patologi gastroenterologi. Jakarta: EGC.1994: 171.
10. Doherty GM, Way LW. Liver and portal venous system. In: Doherty GM, Way LW.
Current surgical diagnosis and treatment, 11th edition. Singapore: Mc Graw Hill.
2003:565-94.
11. Cotran RS,Kumar V,Collins T. Robbins: Pathologic, Basis of disease, 6 th edition.
Philadelphia:WB Saunders Co. 1999:1-112.
12. Moslen MT. Toxic responses of the liver. In : Klaassen CD, editor. Casarett and
doull’s toxicology the basic sciences of poisons, 6th ed. New York USA: Mc Graw
Hill Co.2001:471-89.
51
13. Koolman J, Rohm KH.Color atlas of Biochemistry. Stuttgart: Georg Thieme Verlag.
1994. Terjemahan Indonesia oleh Dr.rer.physiol Septelia Inawati Winandi, dr.
Jakarta: Hipokrates. 1995;286-88.
14. Zunilda SB, Setiawati A, Suyatna FD. Pengantar farmakologi. Dalam: Ganiswarna
SG, Setiabudi R, Suyatna ED, Purwantyastuti, Nafrialdi, editors. Farmakologi dan
terapi, edisi 4(cetak ulang 2001). Jakarta: Bagian Farmakologi FK UI. 1995; 1-23..
15. Murray RK. Metabolism of xenobiotics. In: Murray RK, Graenner DK, Mayes PA,
Rodwell VW. Harper’s Biochemistry, 25 th ed. New York: Mc Graw Hill Co. 2000:
780-811.
16. Correia MA. Drug biotransformation. In: Katzung BG. Basic and Clinical
pharmacology, 8 th edition. New York: Mc Graw Hill Co. 2001: 51-63.
17. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003; 349: 474-85.
18. Ferner RE. Forensic pharmacology:medicine, mayhem and malpractice. New York:
Oxford University Press. 1996; 176-79.
19. Munstehjelm E, Munstehjelm NM, Niemi TT, Ylikorkala O, Neuvonen PJ,
Rosenberg PH. Dose-dependent inhibition acetaminophen in healthy volunteer. J
Anesthesiology 2005;103: 712-17.
20. Barille FA. Clinical Toxicology: principles and mechanism.Boca Raton London
New York Washington DC:CRC Press.2004;69-71.
21. Lee WM. Acute liver failure. N Engl J Med 1993 Dec 16 ; 329 : 1862-72.
22. Navarro VJ, Senior JR. Drug related hepatotoxicity. N Engl J Med 2006;354:731-39.
23. Sudiono J, Kurniadhi B, Hendrawan A, Djimantoro B. Ilmu patologi. Jakarta : EGC.
2003; 13-28.
52
24. Stevens A, Lowe JS, Young B. Wheather’s basic histopathology: a colour atlas and
text, 4th ed. Sydney: Churchill Livingstone. 2002; 6, 154-64.
25. Sacher RA, Mc Pherson RA. Wildman’s clinical interpretation of laboratory tests,
11th ed. Terjemahan Indonesia oleh Pendit U, Wulandari D. Jakarta:EGC.2004; 36085.
26. Fischbach F. A manual of laboratory and diagnostic tests, 7th ed. Wisconsin USA:
Lippincott Williams & Wilkins.2004; 386-88.
27. Wilmana FP. Analgesik-antipiretik, analgesik anti-inflamasi nonsteroid dan obat
pirai. Dalam: Ganiswarna SG, Setiabudi R, Suyatna ED, Purwantyastuti, Nafrialdi,
editors. Farmakologi dan terapi, edisi 4(cetak ulang 2001). Jakarta: Bagian
Farmakologi FK UI. 1995; 214-15.
28. Furst DE, Munster T. Non steroidal anti-inflamatory drugs, disease-modifying
antirheumatic drugs, non opioid analgesics, & drugs used in gout. In: Katzung BG.
Basic and Clinical pharmacology, 8 th ed. New York USA: Mc Graw Hill Co. 2001:
614-16.
29. Gregus Z, Klaassen CD. Mechanisms of toxiciyt. In : Klaassen CD, editor. Casarett
and doull’s toxicology the basic sciences of poisons, 6th ed. New York USA: Mc
Graw Hill Co.2001:57-64.
30. Ito Y, Abril ER, Bethea NW, McCuskey RS. Role of nitric oxide in hepatic
microvascular injury elicited by acetaminophen in mice. In: Gastrointest Liver
physiology. Am J Physiol 2004; 286:G60-G67.
31. Wallace JL. Acetaminophen hepatotoxicity: NO to the rescue. British Journal of
Pharmacology 2004; 143: 1-2.
53
32. Jaeschke H, Knight TR, Bajt ML. The role of oxidant stress and reactive nitrogen
species in acetaminophen hepatotoxicity. Toxicol Lett 2003;144(3): 279-88.
33. Liu J, et al. The nitric oxide donor, V-PYRRO/NO, protects against acetaminopheninduced hepatotoxicity in mice. Hepatology 2003;37(2) : 324-33.
34. Jaeschke H, Bajt ML. Intracellular signaling mechanisms of acetaminophen-induced
liver cell death. Toxicological sciences 2006;89(1):31-41.
35. Knight B. Forensic pathology, 2 nd edition. New York : Oxford University Press.
1997; 563-64.
36. Sass DA, Shakil AO. Fulminant hepatic failure. Gastroenterol Clin N Am
2003;32:1195-211.
37. Laura P James, Wells E, Beard RH, Farrar HC. Predictor of outcome after
acetaminophen poisoning in children and adolescent. Journal of pediatrics 2002
May; 140(5). St Louis USA: Mosby Inc, 2002 .
38. Hogaboam CM, et all. Exaggerated hepatic injury due to acetaminophen challenge in
mice lacking C-C chemokine receptor 2. The American Journal of Pathology 2000;
156 (4): 1245-52.
39. Silvilotti ML, Yarema MC, Juurlink DN, Good AM, Johnson DW. A risk
quantification instrument for acute acetaminophen overdose patients treated with Nacetylcystein. Ann Emerg Med 2005;46: 263-71.
40. Daly FFS, O,Malley G, Heard K, Bogdan GM, Dart RC. Prospective evaluation of
repeated supratherapeutic acetaminophen (paracetamol) ingestion. Ann Emerg Med
2004;44:393-98.
54
41. Brooks DE, Yealy DM. Not enough relief from too much acetaminophen. Ann
Emerg Med 2004;44:399-400.
42. Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban
county hospital. N Engl J Med 1997;337 : 1112-17.
43. Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J of Toxicol. Clinical
Toxicology 2002;40(1): 3-20.
44. Kerr F, et al. The Australasian clinical toxicology Investigators collaboration
Randomized trial of different loading infusion rates of N-Acetylcystein. Ann Emerg
Med 2005 April; 45(4).
45. Bond GR. A new acetaminophen nomogram with a different purpose. Ann Emerg
Med 2005;46: 272-74.
46. James LP, Wells E, Beard RH, Farrar HC. Predictors of outcome after
acetaminophen poisoning in children and adolescents. Journal of Pediatrics May
2002; 140(5).
47. Grunnet N, Tygstrup N, Dich J. Autoprotection against acetaminophen toxicity in
cultured rat hepatocytes: the effect of pretreatment and growth factors. Pharmacol
toxicol 2003;93(3): 135-41.
48. Aleksunes LM, Slitt AM, Cherrington NJ, Thibodeau MS, Klaassen CD, Manautou
JE. Differential expression of mouse hepatic transporter genes in response to
acetaminophen and carbon tetrachloride.Toxsci 2004;83 : 44-52.
49. Junqueira LC, Carneiro J, Kelley RO. Basic histology. Terjemahan indonesia oleh
Jan Tambayong. Jakarta 1998 : EGC ; 317-26.
55
1. MediMedia. MIMS Indonesia 1994; 23 (3). Singapore:MediMedia. 1994.
2. MediMedia. MIMS Indonesia 2003; 32 (2). Singapore:MediMedia. 2003.
3. Moynihan R. FDA fails to reduce accessibility of paracetamol despite 450 deaths a
year. BMJ 2002 Sept 28; 325..
4. Siker BPOM. Data keracunan parasetamol di Indonesia tahun 2002-2005, BPOM,
2006.
5. Schiodt FV, Lee WM. Fulminant liver disease. Clin Liver Dis 2003;7:331-49
6. Bromer MQ, Black M. Acetaminophen hepatotoxicity. Clin Liver Dis 2003;7:351-67
7. Martini. Fundamental of Anatomy and Physiology, 5th ed. London: Prentice Hall
Inc. 1999-2000.
8. Huether SE, Kathryn MC. Understanding Patophysiology, 2 nd edition. St Louis
USA: Mosby Inc. 2000: 931-33.
9. Tambunan GW. Patologi gastroenterologi. Jakarta: EGC.1994: 171.
10. Doherty GM, Way LW. Liver and portal venous system. In: Doherty GM, Way LW.
Current surgical diagnosis and treatment, 11th edition. Singapore: Mc Graw Hill.
2003:565-94.
11. Cotran RS,Kumar V,Collins T. Robbins: Pathologic, Basis of disease, 6 th edition.
Philadelphia:WB Saunders Co. 1999:1-112.
12. Moslen MT. Toxic responses of the liver. In : Klaassen CD, editor. Casarett and
doull’s toxicology the basic sciences of poisons, 6th ed. New York USA: Mc Graw
Hill Co.2001:471-89.
51
13. Koolman J, Rohm KH.Color atlas of Biochemistry. Stuttgart: Georg Thieme Verlag.
1994. Terjemahan Indonesia oleh Dr.rer.physiol Septelia Inawati Winandi, dr.
Jakarta: Hipokrates. 1995;286-88.
14. Zunilda SB, Setiawati A, Suyatna FD. Pengantar farmakologi. Dalam: Ganiswarna
SG, Setiabudi R, Suyatna ED, Purwantyastuti, Nafrialdi, editors. Farmakologi dan
terapi, edisi 4(cetak ulang 2001). Jakarta: Bagian Farmakologi FK UI. 1995; 1-23..
15. Murray RK. Metabolism of xenobiotics. In: Murray RK, Graenner DK, Mayes PA,
Rodwell VW. Harper’s Biochemistry, 25 th ed. New York: Mc Graw Hill Co. 2000:
780-811.
16. Correia MA. Drug biotransformation. In: Katzung BG. Basic and Clinical
pharmacology, 8 th edition. New York: Mc Graw Hill Co. 2001: 51-63.
17. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003; 349: 474-85.
18. Ferner RE. Forensic pharmacology:medicine, mayhem and malpractice. New York:
Oxford University Press. 1996; 176-79.
19. Munstehjelm E, Munstehjelm NM, Niemi TT, Ylikorkala O, Neuvonen PJ,
Rosenberg PH. Dose-dependent inhibition acetaminophen in healthy volunteer. J
Anesthesiology 2005;103: 712-17.
20. Barille FA. Clinical Toxicology: principles and mechanism.Boca Raton London
New York Washington DC:CRC Press.2004;69-71.
21. Lee WM. Acute liver failure. N Engl J Med 1993 Dec 16 ; 329 : 1862-72.
22. Navarro VJ, Senior JR. Drug related hepatotoxicity. N Engl J Med 2006;354:731-39.
23. Sudiono J, Kurniadhi B, Hendrawan A, Djimantoro B. Ilmu patologi. Jakarta : EGC.
2003; 13-28.
52
24. Stevens A, Lowe JS, Young B. Wheather’s basic histopathology: a colour atlas and
text, 4th ed. Sydney: Churchill Livingstone. 2002; 6, 154-64.
25. Sacher RA, Mc Pherson RA. Wildman’s clinical interpretation of laboratory tests,
11th ed. Terjemahan Indonesia oleh Pendit U, Wulandari D. Jakarta:EGC.2004; 36085.
26. Fischbach F. A manual of laboratory and diagnostic tests, 7th ed. Wisconsin USA:
Lippincott Williams & Wilkins.2004; 386-88.
27. Wilmana FP. Analgesik-antipiretik, analgesik anti-inflamasi nonsteroid dan obat
pirai. Dalam: Ganiswarna SG, Setiabudi R, Suyatna ED, Purwantyastuti, Nafrialdi,
editors. Farmakologi dan terapi, edisi 4(cetak ulang 2001). Jakarta: Bagian
Farmakologi FK UI. 1995; 214-15.
28. Furst DE, Munster T. Non steroidal anti-inflamatory drugs, disease-modifying
antirheumatic drugs, non opioid analgesics, & drugs used in gout. In: Katzung BG.
Basic and Clinical pharmacology, 8 th ed. New York USA: Mc Graw Hill Co. 2001:
614-16.
29. Gregus Z, Klaassen CD. Mechanisms of toxiciyt. In : Klaassen CD, editor. Casarett
and doull’s toxicology the basic sciences of poisons, 6th ed. New York USA: Mc
Graw Hill Co.2001:57-64.
30. Ito Y, Abril ER, Bethea NW, McCuskey RS. Role of nitric oxide in hepatic
microvascular injury elicited by acetaminophen in mice. In: Gastrointest Liver
physiology. Am J Physiol 2004; 286:G60-G67.
31. Wallace JL. Acetaminophen hepatotoxicity: NO to the rescue. British Journal of
Pharmacology 2004; 143: 1-2.
53
32. Jaeschke H, Knight TR, Bajt ML. The role of oxidant stress and reactive nitrogen
species in acetaminophen hepatotoxicity. Toxicol Lett 2003;144(3): 279-88.
33. Liu J, et al. The nitric oxide donor, V-PYRRO/NO, protects against acetaminopheninduced hepatotoxicity in mice. Hepatology 2003;37(2) : 324-33.
34. Jaeschke H, Bajt ML. Intracellular signaling mechanisms of acetaminophen-induced
liver cell death. Toxicological sciences 2006;89(1):31-41.
35. Knight B. Forensic pathology, 2 nd edition. New York : Oxford University Press.
1997; 563-64.
36. Sass DA, Shakil AO. Fulminant hepatic failure. Gastroenterol Clin N Am
2003;32:1195-211.
37. Laura P James, Wells E, Beard RH, Farrar HC. Predictor of outcome after
acetaminophen poisoning in children and adolescent. Journal of pediatrics 2002
May; 140(5). St Louis USA: Mosby Inc, 2002 .
38. Hogaboam CM, et all. Exaggerated hepatic injury due to acetaminophen challenge in
mice lacking C-C chemokine receptor 2. The American Journal of Pathology 2000;
156 (4): 1245-52.
39. Silvilotti ML, Yarema MC, Juurlink DN, Good AM, Johnson DW. A risk
quantification instrument for acute acetaminophen overdose patients treated with Nacetylcystein. Ann Emerg Med 2005;46: 263-71.
40. Daly FFS, O,Malley G, Heard K, Bogdan GM, Dart RC. Prospective evaluation of
repeated supratherapeutic acetaminophen (paracetamol) ingestion. Ann Emerg Med
2004;44:393-98.
54
41. Brooks DE, Yealy DM. Not enough relief from too much acetaminophen. Ann
Emerg Med 2004;44:399-400.
42. Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban
county hospital. N Engl J Med 1997;337 : 1112-17.
43. Rumack BH. Acetaminophen hepatotoxicity: the first 35 years. J of Toxicol. Clinical
Toxicology 2002;40(1): 3-20.
44. Kerr F, et al. The Australasian clinical toxicology Investigators collaboration
Randomized trial of different loading infusion rates of N-Acetylcystein. Ann Emerg
Med 2005 April; 45(4).
45. Bond GR. A new acetaminophen nomogram with a different purpose. Ann Emerg
Med 2005;46: 272-74.
46. James LP, Wells E, Beard RH, Farrar HC. Predictors of outcome after
acetaminophen poisoning in children and adolescents. Journal of Pediatrics May
2002; 140(5).
47. Grunnet N, Tygstrup N, Dich J. Autoprotection against acetaminophen toxicity in
cultured rat hepatocytes: the effect of pretreatment and growth factors. Pharmacol
toxicol 2003;93(3): 135-41.
48. Aleksunes LM, Slitt AM, Cherrington NJ, Thibodeau MS, Klaassen CD, Manautou
JE. Differential expression of mouse hepatic transporter genes in response to
acetaminophen and carbon tetrachloride.Toxsci 2004;83 : 44-52.
49. Junqueira LC, Carneiro J, Kelley RO. Basic histology. Terjemahan indonesia oleh
Jan Tambayong. Jakarta 1998 : EGC ; 317-26.
55